SUSQUEHANNA INTERNATIONAL GROUP, LLP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$87,376,425
-13.4%
857,809
-14.2%
0.02%
-14.3%
Q2 2023$100,927,155
+7.2%
1,000,170
-2.3%
0.02%
+10.5%
Q1 2023$94,153,352
-32.8%
1,023,406
-33.7%
0.02%
-47.2%
Q4 2022$140,131,192
+49.6%
1,544,656
+25.3%
0.04%
+50.0%
Q3 2022$93,667,000
-1.9%
1,232,293
+9.0%
0.02%0.0%
Q2 2022$95,528,000
-26.4%
1,130,103
-23.5%
0.02%
+4.3%
Q1 2022$129,714,000
-42.3%
1,478,215
-42.5%
0.02%
+228.6%
Q4 2021$224,974,000
+106.0%
2,572,000
+92.6%
0.01%
-50.0%
Q3 2021$109,232,000
+31.3%
1,335,683
+46.5%
0.01%
+27.3%
Q2 2021$83,210,000
-9.4%
912,000
-15.1%
0.01%
-21.4%
Q1 2021$91,815,000
-64.9%
1,074,111
-61.2%
0.01%
-36.4%
Q4 2020$261,342,000
+138.2%
2,767,590
+119.4%
0.02%
+10.0%
Q3 2020$109,699,000
+17.5%
1,261,493
+18.0%
0.02%
-9.1%
Q2 2020$93,357,000
+16.8%
1,068,900
+10.2%
0.02%
-15.4%
Q1 2020$79,951,000
-13.7%
969,700
-0.9%
0.03%0.0%
Q4 2019$92,690,000
+1.3%
978,878
-7.1%
0.03%
-13.3%
Q3 2019$91,523,000
-74.1%
1,053,200
-72.8%
0.03%
-31.8%
Q2 2019$353,706,000
+365.3%
3,873,681
+389.9%
0.04%
+46.7%
Q1 2019$76,023,000
+28.1%
790,759
+14.4%
0.03%
+30.4%
Q4 2018$59,329,000
+25.5%
691,400
+26.0%
0.02%
+53.3%
Q3 2018$47,285,000
+15.0%
548,800
+0.8%
0.02%
+7.1%
Q2 2018$41,109,000
-15.8%
544,200
-9.9%
0.01%
-22.2%
Q1 2018$48,834,000
+96.9%
604,000
+104.5%
0.02%
+100.0%
Q4 2017$24,802,000
+97.9%
295,400
+102.3%
0.01%
+80.0%
Q3 2017$12,534,000
-68.7%
146,000
-69.6%
0.01%
-72.2%
Q2 2017$40,049,000
+52.2%
479,800
+35.4%
0.02%
+28.6%
Q1 2017$26,314,000
-10.7%
354,300
-12.4%
0.01%
-6.7%
Q4 2016$29,464,000
+15.9%
404,500
+25.7%
0.02%
+25.0%
Q3 2016$25,417,000
-23.3%
321,900
-19.8%
0.01%
-33.3%
Q2 2016$33,128,000
+27.2%
401,500
+11.7%
0.02%
+28.6%
Q1 2016$26,047,000
-25.9%
359,565
-12.0%
0.01%
-12.5%
Q4 2015$35,144,000
+12.1%
408,463
+19.8%
0.02%
+14.3%
Q3 2015$31,353,000
-43.2%
341,090
-39.3%
0.01%
-39.1%
Q2 2015$55,227,000
+112.9%
561,600
+113.5%
0.02%
+109.1%
Q1 2015$25,935,000
+47.6%
263,000
+38.7%
0.01%
+83.3%
Q4 2014$17,567,000
+21.1%
189,592
+23.0%
0.01%0.0%
Q3 2014$14,511,000
-51.1%
154,160
-53.0%
0.01%
-53.8%
Q2 2014$29,666,000
-35.5%
327,700
-39.4%
0.01%
-38.1%
Q1 2014$45,960,000
-41.0%
540,579
-44.2%
0.02%
-41.7%
Q4 2013$77,878,000
+72.4%
968,884
+64.6%
0.04%
+50.0%
Q3 2013$45,167,000
+9.7%
588,800
+1.2%
0.02%
+4.3%
Q2 2013$41,157,000582,0650.02%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 237,047$19,165,0006.16%
PRENTISS SMITH & CO INC 127,005$10,268,0005.38%
EXENCIAL WEALTH ADVISORS, LLC 195,903$15,839,0004.71%
Osher Van de Voorde Investment Management 106,315$8,596,0004.37%
BROWN BROTHERS HARRIMAN & CO 8,924,544$721,549,0004.16%
CGOV Asset Management 874,998$70,744,0004.08%
PROFESSIONAL ADVISORY SERVICES INC 218,844$17,694,0003.83%
COMPASS CAPITAL MANAGEMENT, INC 304,931$24,654,0003.69%
First Fiduciary Investment Counsel, Inc. 226,636$18,324,0003.64%
SUMMITRY LLC 456,575$36,914,0003.41%
View complete list of NOVARTIS A G shareholders